1. Home
  2. LIDR vs TENX Comparison

LIDR vs TENX Comparison

Compare LIDR & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AEye Inc.

LIDR

AEye Inc.

HOLD

Current Price

$1.83

Market Cap

69.8M

ML Signal

HOLD

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

HOLD

Current Price

$14.95

Market Cap

56.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LIDR
TENX
Founded
2013
1967
Country
United States
United States
Employees
45
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
69.8M
56.2M
IPO Year
N/A
2001

Fundamental Metrics

Financial Performance
Metric
LIDR
TENX
Price
$1.83
$14.95
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$6.00
$29.67
AVG Volume (30 Days)
4.4M
417.7K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$2,510.73
N/A
Revenue Next Year
$486.88
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$4.64
52 Week High
$6.44
$18.38

Technical Indicators

Market Signals
Indicator
LIDR
TENX
Relative Strength Index (RSI) 49.46 55.31
Support Level $1.80 $12.71
Resistance Level $2.65 $16.27
Average True Range (ATR) 0.27 1.31
MACD -0.02 0.10
Stochastic Oscillator 25.00 48.12

Price Performance

Historical Comparison
LIDR
TENX

About LIDR AEye Inc.

AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

Share on Social Networks: